Biodesix, Inc.

NasdaqGM:BDSX Stock Report

Market Cap: US$180.4m

Biodesix Future Growth

Future criteria checks 1/6

Biodesix is forecast to grow earnings and revenue by 35.9% and 19.7% per annum respectively while EPS is expected to grow by 47.6% per annum.

Key information

35.9%

Earnings growth rate

47.6%

EPS growth rate

Healthcare earnings growth21.1%
Revenue growth rate19.7%
Future return on equityn/a
Analyst coverage

Good

Last updated04 Nov 2024

Recent future growth updates

Recent updates

Does Biodesix (NASDAQ:BDSX) Have A Healthy Balance Sheet?

Sep 24
Does Biodesix (NASDAQ:BDSX) Have A Healthy Balance Sheet?

Biodesix, Inc.'s (NASDAQ:BDSX) Popularity With Investors Is Clear

Jun 12
Biodesix, Inc.'s (NASDAQ:BDSX) Popularity With Investors Is Clear

With A 25% Price Drop For Biodesix, Inc. (NASDAQ:BDSX) You'll Still Get What You Pay For

Mar 03
With A 25% Price Drop For Biodesix, Inc. (NASDAQ:BDSX) You'll Still Get What You Pay For

Biodesix, Inc.'s (NASDAQ:BDSX) P/S Is Still On The Mark Following 28% Share Price Bounce

Jan 04
Biodesix, Inc.'s (NASDAQ:BDSX) P/S Is Still On The Mark Following 28% Share Price Bounce

It's Down 28% But Biodesix, Inc. (NASDAQ:BDSX) Could Be Riskier Than It Looks

Jul 16
It's Down 28% But Biodesix, Inc. (NASDAQ:BDSX) Could Be Riskier Than It Looks

A Second Look At Biodesix

Oct 18

Biodesix expects Q3 revenue above the consensus

Oct 11

Biodesix GAAP EPS of -$0.40 beats by $0.07, revenue of $10.95M beats by $2.12M

Aug 04

Biodesix: Bad Diagnosis

May 26

Analysts' Revenue Estimates For Biodesix, Inc. (NASDAQ:BDSX) Are Surging Higher

Mar 15
Analysts' Revenue Estimates For Biodesix, Inc. (NASDAQ:BDSX) Are Surging Higher

Need To Know: Analysts Just Made A Substantial Cut To Their Biodesix, Inc. (NASDAQ:BDSX) Estimates

Nov 25
Need To Know: Analysts Just Made A Substantial Cut To Their Biodesix, Inc. (NASDAQ:BDSX) Estimates

Earnings and Revenue Growth Forecasts

NasdaqGM:BDSX - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/2026113-26-7-113
12/31/202592-34-18-176
12/31/202471-45-53-556
9/30/202466-44-62-57N/A
6/30/202461-45-61-50N/A
3/31/202455-47-46-30N/A
12/31/202349-52-46-23N/A
9/30/202344-63-45-23N/A
6/30/202342-66-46-29N/A
3/31/202341-69-50-40N/A
12/31/202238-65-49-45N/A
9/30/202236-58-45-43N/A
6/30/202231-56-43-41N/A
3/31/202232-52-32-30N/A
12/31/202155-43-31-28N/A
9/30/202174-34-29-27N/A
6/30/202177-32-26-23N/A
3/31/202169-29-31-28N/A
12/31/202046-31-24-21N/A
9/30/202027-33-22-18N/A
6/30/202022-34-23-21N/A
3/31/202023-33-23-21N/A
12/31/201925-31-24-22N/A
12/31/201820-26-18-18N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: BDSX is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: BDSX is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: BDSX is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: BDSX's revenue (19.7% per year) is forecast to grow faster than the US market (8.9% per year).

High Growth Revenue: BDSX's revenue (19.7% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if BDSX's Return on Equity is forecast to be high in 3 years time

Discover growth companies

7D

1Y

7D

1Y

7D

1Y